The Effects of Orexin Antagonism on Fear Extinction in PTSD (NCT06788522)
🩺 Plain-English Summary (8th-Grade Level)
PTSD affects approximately 22% of Veterans who have served in Iraq and Afghanistan. Symptoms of PTSD may include re-experiencing, avoidance of trauma reminders, negative thoughts or feelings, and hyperarousal, such as increased startle reactivity and disturbed sleep. Treatments for PTSD are based on fear extinction principles in which individuals are repeatedly exposed a feared cue in the absence of danger, resulting in diminishing physiological reactions, a process believed to underlie recovery from PTSD. Studies suggest that orexin, a wake-promoting neuropeptide, may enhance fear extinction. This study will examine whether suvorexant, a selective orexin-receptor antagonist, will enhance fear extinction in Veterans with PTSD and insomnia. Finding a role for orexins in fear extinction will support the rationale for its further evaluation in the treatment of PTSD. Suvorexant is an accessible, safe medication that has been well-established in treating insomnia. It has outstanding promise for treating common and distressing symptoms in Veterans with PTSD.
Who can join: Review the eligibility criteria below.
Location: San Francisco VA Medical Center, San Francisco, CA — San Francisco, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- San Francisco VA Medical Center, San Francisco, CA — San Francisco, California
- Ralph H. Johnson VA Medical Center, Charleston, SC — Charleston, South Carolina
📞 Contact the Study Coordinator
Phone: (415) 221-4810
Email: sabra.inslicht@va.gov
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Insomnia
- RISE: A Remote Study of Insomnia Treatment in Crohn's Disease — Lebanon, New Hampshire
- Perinatal Research on Improving Sleep and Mental Health — San Francisco, California
- Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application — Boston, Massachusetts
- Wearable Transcranial Electrical Stimulation (tES) for Insomnia — Bethesda, Maryland
- Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial — New York, New York
- Remote STATE Training for Insomnia in Older Adults — San Francisco, California
Explore by condition: All Insomnia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.